
    
      For participant who declines to enter open-lebal extension (OLE), the duration of the study
      for each participant is approximately 33 weeks (including screening and follow-up) For
      participant choosing enter OLE, the duration is approximately 21 weeks (including screening)
      plus 3 years OLE period or until approval of the indication in Japan whichever is sooner.
    
  